HCV Advocate – Direct-Acting Antiviral Treatment & Decrease a Incidence of Liver Cancer

In Case You Missed It

SnapShots – Direct-Acting Antiviral Treatment & Decrease a Incidence of Liver Cancer
Alan Franciscus

Did you know that people who were treated with direct-acting antiviral (DAA) medications….

• Were significantly less likely to die than the people who were untreated.
• Had at least a 20% decrease in liver fibrosis after 24-weeks of the completion of DAA therapy
• Experienced a 71% reduction in liver cancer risk after being cured with a DAA medication.

 The studies on this blog looked at treatment with DAAs to find out if curing hepatitis C (HCV) with DAAs improved HCV disease progression and reduced the risk of liver cancer.

Continue reading........